CSL LIMITED ORDINARY (CSL) Short Interest
CSL LIMITED ORDINARY (ASX:CSL) had 1.14% of shares reported as short positions as of 16 July 2026, representing 5,445,224 shares. CSL LIMITED ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Csl
CSL Limited is a global biotechnology company specializing in the development, manufacturing, and marketing of life-saving biotherapies, vaccines, and diagnostic products. Its core business revolves around plasma-derived therapies, which treat a range of serious medical conditions, and recombinant technologies. CSL holds a leading market position in several therapeutic areas, leveraging its extensive research and development capabilities and global manufacturing and distribution network to deliver innovative healthcare solutions.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4CSL intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Csl
Latest CSL news
All news- CSL Stock And 2 Income Shares For Steadier Dividends - simplywall.st
googlenews
- How have CSL shares performed over 10 years?
motleyfool
- How Margin Pressures, Impairments and Leadership Shifts At CSL (ASX:CSL) Have Changed Its Investment Story - simplywall.st
googlenews
- Why Is Australia’s CSL Bluechip Story Facing A New Test?
kalkine
- CSL (ASX:CSL) Leads A Healthcare Rebound Few Saw Coming
kalkine
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss CSL
Start a research thread or post the first pulse update